How Pharmacy Businesses Are Valued in Georgia
The standard valuation methodology for a pharmacy uses revenue/prescription count multiple, with typical transaction multiples of 0.2-0.5x revenue or $3-8 per Rx. In Georgia, local market conditions—including the Atlanta, Augusta, Savannah metropolitan areas—influence where a specific business falls within that range.
Independent pharmacies are valued on revenue multiples or a per-prescription basis, with adjustments for PBM reimbursement mix, specialty drug percentage, and 340B participation. Specialty and compounding pharmacies command significant premiums over traditional retail.
The Georgia Business Environment
Georgia's economy is anchored by Atlanta, a top-10 U.S. metro area and headquarters to multiple Fortune 500 companies. The state has a flat 5.49% income tax rate and is a major logistics hub due to Hartsfield-Jackson airport and the Port of Savannah.
Atlanta's deep buyer pool and corporate concentration make Georgia one of the most active M&A markets in the Southeast.
Georgia's state income tax should be factored into after-tax proceeds analysis when evaluating sale offers.
Key Value Drivers for Pharmacy Businesses in Georgia
- Prescription volume and growth
- Specialty/compounding revenue
- 340B program participation
- PBM contract terms
Georgia Market Considerations
The major metro areas in Georgia—Atlanta, Augusta, Savannah, Columbus—each have distinct competitive dynamics that affect pharmacy valuations. Businesses in larger metros typically command higher multiples due to larger addressable markets and deeper buyer pools, while rural Georgia businesses may trade at a discount but often have less competition and stronger community ties.
With 1,200,000+ small businesses statewide and a population of 11.0M, Georgia represents a major market for pharmacy transactions. Buyers evaluating pharmacy businesses in Georgia will factor in regional competition, labor market conditions, and local regulatory requirements.